Relieving Pain. Restoring Lives.

Our approach

Keimon Medical has developed an innovative solution that quickly and cost-effectively delivers transformational, long-term pain relief through a unique outpatient device-based treatment. The minimally invasive, high throughput, office-based approach is fully repeatable at pain re-occurrence and supersedes the current state of the art by better effect, better adverse event profile and lower cost.

We are currently advancing a pipeline of candidate targets in multiple pain conditions to bring much needed pain relief where it is needed the most.

About us

Keimon Medical is a spin out company from Trondheim University Hospital and Norwegian University of Science and Technology. Drawing upon research conducted at one of Europe’s premier research centers specializing in headache and facial pain, we have meticulously developed a transformative method for pain treatment applicable to a diverse range of pain conditions.

Team

Our team is commited to scientific excellence and a genuine passion for delivering innovative therapies to those in need.

We possess a profound understanding of pain disorders and their underlying mechanisms, offering an unprecedented opportunity for significant breakthroughs in pain treatment.

Daniel Bratbak
Co-founder & CEO

Daniel Bratbak is an associate professor and a senior consultant in neurosurgery at St. Olav Hospital. He has been conducting innovative research since 2012, focusing on developing minimally invasive procedures for treating pain conditions of the head. He is a serial entrepreneur with experience as CSO in international med tech companies. He co-founded and was first employee in Palion Medical, a company that was successfully acquired in 2022.

Erling Tronvik
Co-founder & Scientific Advisor

Erling Tronvik is a professor and a senior consultant in neurology. He leads the National Competence Center for Headaches, as well as the NorHead – Norwegian Centre for Headache Research. He is a serial entrepreneur, and co-founded Palion Medical which was successfully acquired in 2022.

Maarten Wigstøl
Chair

Maarten Wigstøl is a senior executive with 32 years of management experience in life-science, diagnostics and medical technology. He is also a professional board member, an investor, a co-founder and a consultant for various startup-companies in different fields.

Medical advisors

Two of the most influential headache and facial pain experts globally

David W. Dodick

Professor at Mayo Clinic, Arizona.
Past-president of the International Headache Society.
Past-president American Headache Society.
Past editor in chief of Cephalalgia.

Manjit Matharu

Professor at The National Hospital for Neurology and Neurosurgery, UK.
Medical Advisory Board of the UK Trigeminal.
Neuralgia and Facial Pain Association.

Contact

Kjøpmannsgt. 40, 7011 Trondheim, Norway
E-mail: contact@keimonmedical.com
Phone: +47 92 02 99 56.

We have been supported directly or through the Norwegian University of Science and Technology by: